08.01.12
Thorne Research, Inc., a manufacturer of nutritional supplements and personal care products marketed through medical professionals, and Helsinn, a growing pharmaceutical group based in Lugano, Switzerland, have rolled out DermaQOL, a line of nine personal care products specially formulated to support the skin-care and hair-care needs of patients undergoing cancer treatment.
Released in connection with the firm's OncoQOL supplements, DermaQOL products are available only through oncologists and other medical professionals in the US and Canada.
"For many cancer patients the side effects of treatment have a significant impact on their health and quality of life, often making it difficult for them to continue with their therapy.Our products are designed to meet the unique needs of these patients and are manufactured with the essential levels of purity and consistency that are so important for this population," said Sreenivas Rao, president, OncoQOL.
DermaQOL personal care products are manufactured without the use of plasticizers, foaming agents, and preservatives found in many personal care product brands. Products include lotion, shower gel and a cooling aloe spray.
"Living with cancer creates many challenges, and treatment can now extend over years. In order to avoid negative interactions, cancer patients should choose products formulated with their needs in mind," said Mary Hardy, MD, medical director, Simms/Mann-UCLA Center for Integrative Oncology.
To date, more than 100 cancer specialists and other health-care providers have signed up to provide these products to their patients.